Fatigue
1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Providence TherapeuticsAB - Calgary
1 programProtected time and Dedicated timeN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Pierre FabreFerrous sulphate
Alliance PharmaceuticalsAmerican ginseng
Providence TherapeuticsProtected time and Dedicated time
Alliance PharmaceuticalsAmerican ginseng
Clinical Trials (4)
Total enrollment: 654 patients across 4 trials
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
Start: Nov 2008Est. completion: Apr 2011
Phase 4Completed
American Ginseng in Treating Patients With Fatigue Caused by Cancer
Start: Oct 2008Est. completion: Aug 2013364 patients
Phase 3Completed
Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts
Start: Oct 2009Est. completion: Sep 2010
N/ATerminated
American Ginseng in Treating Patients With Cancer-Related Fatigue
Start: Oct 2005Est. completion: Apr 2010290 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space